“5TH PHARMACOVIGILANCE CONGREGATION 2013”
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “5th Pharmacovigilance Congregation 2013” The conference will be held on 20th November 2013, Kohinoor Continental Hotel, Mumbai, India.
- Deepa Arora, Global Head, Drug Safety & Risk Management, Lupin
- Arun Bhatt, President, Clininvent Research
- Moin Don, Executive Director, PVCON Pharmacovigilance Auditing & Consulting Services
- Bhaswat Chakraborty, Senior Vice President, Research & Development, Cadila Pharmaceuticals
- Parminder Kaur, Owner & Regulatory Affairs & PhV Consultant (QPPV), RegPak BioPharma Consulting (Netherlands, UK)
- Babita Kirodian, Head – Pharmacovigilance, Bristol-Myers Squibb
- Rajani Rokade, Head – Pharmacovigilance, Sanofi Aventis
- Veena Rajan, Head – Patient Safety, AstraZeneca
- Sofi Joseph, Head –…
View original post 465 more words